Please send me updates by newsletter.

QuikVue Vet Case Study—Corneal Ulcer with Intraocular Hemorrhage

03/25/25

We are glad to share a vet case study captured by QuikVue eye imaging adaptor from Dr.Allison Fuchs.

 

Can you guess what concerned me most about this patient? I’ll give you a hint, it’s not the cornea! This young dog was referred for a deep ulcer, and he does indeed have a gnarly descemetocele. Any other day we’d be heading to surgery to graft this, either with a conjunctival pedicle or corneal-conjunctival transposition. However, this dog is bleeding into his iris. In BOTH eyes. This puts a hard stop on surgery, at least for me, until we figure out why and what his risk is of spontaneous bleeding. He is also a brachycephalic breed and already at higher risk of peri-anesthetic complications! We did a thorough systemic workup, including coagulation tests and platelet function (yes I had to do a BMBT!) and his tests all came back relatively normal. Good news, but also bad because it means we don’t have a cause. Due to the risks and in absence of finding an underlying etiology for the bleeding, we elected to start aggressive medical therapy for the eye, and systemic therapy with an antibiotic that covers most tick-borne diseases. Thankfully he is improving rapidly, both in regards to the ulcer and the bleeding. Super weird case, and once again a reminder of evaluating the entire patient even when faced with a scary looking eyeball!





We are glad to share a vet case study captured by QuikVue eye imaging adaptor from Dr.Allison Fuchs.

 

Can you guess what concerned me most about this patient? I’ll give you a hint, it’s not the cornea! This young dog was referred for a deep ulcer, and he does indeed have a gnarly descemetocele. Any other day we’d be heading to surgery to graft this, either with a conjunctival pedicle or corneal-conjunctival transposition. However, this dog is bleeding into his iris. In BOTH eyes. This puts a hard stop on surgery, at least for me, until we figure out why and what his risk is of spontaneous bleeding. He is also a brachycephalic breed and already at higher risk of peri-anesthetic complications! We did a thorough systemic workup, including coagulation tests and platelet function (yes I had to do a BMBT!) and his tests all came back relatively normal. Good news, but also bad because it means we don’t have a cause. Due to the risks and in absence of finding an underlying etiology for the bleeding, we elected to start aggressive medical therapy for the eye, and systemic therapy with an antibiotic that covers most tick-borne diseases. Thankfully he is improving rapidly, both in regards to the ulcer and the bleeding. Super weird case, and once again a reminder of evaluating the entire patient even when faced with a scary looking eyeball!





Recent Blogs

Try Digital Slit-Lamp Imaging Before You Buy: EyeStream 7-Day U.S. Trial

Try Digital Slit-Lamp Imaging Before You Buy: EyeStream 7-Day U.S. Trial

EyeStream helps clinics add digital photo, video, meibography, fluorescein-supported imaging, and VisuDoc documentation to compatible slit lamps. With the 7-day U.S. trial, clinicians can evaluate the workflow in their own exam room before making a purchase decision.

07-01,2026
MeiboVue in Sjögren's Dry Eye: Tracking Severe Gland Dropout When Symptoms Improve

MeiboVue in Sjögren's Dry Eye: Tracking Severe Gland Dropout When Symptoms Improve

After multimodal dry-eye care, symptoms may improve — but clinicians still need to know whether severe meibomian gland dropout is stable or progressing. MeiboVue supports portable baseline and follow-up meibography in pre-test or chairside flow. One de-identified case shows before/after comparison alongside qualified clinical findings.

06-23,2026
Four Cases: What AnterVue Imaging Can Help You Show

Four Cases: What AnterVue Imaging Can Help You Show

The following de-identified captures illustrate four common scleral lens scenarios. Images show visible findings for discussion—not standalone proof of fit quality or required lens changes.

06-16,2026